CELU Earnings & Financial Statements
Celularity Inc.
$1.33
+$0.02(+1.53%)
50
Overall
40
Value
66
Tech
44
Quality
Market Cap
$42.51M
Volume
30.59K
52W Range
$0.56 - $2.55
Target Price
$6.00
CELU earnings and financial statements: Celularity Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CELU Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $26.55M | $54.22M | $22.77M | $17.98M | $21.34M |
| Cost of revenue | $20.07M | $14.99M | $16.02M | $19.66M | $9.65M |
| Operating income | -$61.31M | -$38.36M | -$192.29M | -$25.60M | -$109.06M |
| EBITDA | -$84.42M | -$49.97M | -$183.95M | $23.64M | -$88.11M |
| Net income | -$91.72M | -$57.89M | -$196.29M | $14.19M | -$100.12M |
| EPS (diluted) | $-3.59 | $-2.64 | $-11.02 | $0.90 | $-1.49 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $107.33M | $132.68M | $143.89M | $401.07M | $414.13M |
| Total liabilities | $145.39M | $123.84M | $102.93M | $202.16M | $314.71M |
| Shareholders’ equity | -$38.06M | $8.84M | $40.96M | $198.90M | $99.42M |
| Cash and equivalents | $6.17M | $738.0K | $227.0K | $13.97M | $37.24M |
| Long-term debt | $26.90M | $26.55M | $26.18M | $27.98M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.25M | -$6.40M | -$38.69M | -$137.88M | -$110.10M |
| Capital expenditure | - | -$1.66M | -$4.05M | -$5.24M | -$6.20M |
| Free cash flow | -$13.25M | -$8.06M | -$42.73M | -$143.11M | -$116.30M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CELU | $1.33 | +1.5% | 30.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |